Key result
Intravenous thrombolysis fails to improve functional recovery over standard care in minor ischemic stroke.
Why the study?
Does intravenous thrombolysis improve functional recovery in patients with minor acute ischemic stroke?
Meta-Analysis
Does intravenous thrombolysis improve functional recovery in patients with minor acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
In patients with minor acute ischemic stroke, intravenous thrombolysis does not confer additional benefit over standard care and is associated with increased risks of hemorrhage and mortality.
Drawing exclusively from randomized controlled trials (RCTs), the meta-analysis by Doheim et al. evaluates the comparative effectiveness of intravenous thrombolysis (IVT) vs nonthrombolytic standard of care (NT-SC) in patients with minor acute ischemic stroke (AIS). The authors identified 9 reports encompassing 13 RCTs. Multiple analytical approaches (Q and I2 measures, leave-out-one analyses, sensitivity analyses) were performed to address study heterogeneity. Findings show that, compared with NT-SC, IVT was not significantly associated with excellent functional recovery poststroke (odds ratio 0.85, 95% CI 0.70–1.03). IVT was associated with lower odds of achieving functional independence and higher odds of symptomatic intracranial hemorrhage and mortality at 90 days. A major strength is the study's exclusive inclusion of RCTs, which minimizes methodological heterogeneity and enhances internal validity. Limitations include (1) small number of included studies precluding formal assessment of publication bias; (2) exclusion of observational or quasiexperimental studies, potentially overlooking valuable real-world evidence; (3) variability in the definition of minor AIS; and (4) insensitivity of conventional outcome measures such as the modified Rankin Scale to capture nonmotor functional deficits such as fatigue and return-to-work capability, which are highly relevant to patients with minor stroke but remain underrepresented in traditional assessments. In conclusion, this meta-analysis suggests that IVT does not confer additional benefit over NT-SC for minor nondisabling stroke. Future studies would benefit from incorporating broader, patient-centered functional outcomes to better capture the subtleties of disability in this patient population.
No takes yet. Share an insight, caveat, or question.
Teo et al. (2026) conducted a meta-analysis in minor acute ischemic stroke (AIS). intravenous thrombolysis (IVT) vs. nonthrombolytic standard of care (NT-SC) was evaluated on excellent functional recovery poststroke (OR 0.85, 95% CI 0.70-1.03). Intravenous thrombolysis was not associated with excellent functional recovery compared with standard of care in minor acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: